DGAP-Adhoc: QIAGEN N.V.: Ad hoc Announcement according to Art. 17 Market Abuse Regulation QIAGEN to conduct an additional up to $100 million share repurchase program

2019. május 06., hétfő, 22:02





DGAP-Ad-hoc: QIAGEN N.V. / Key word(s): Share Buyback


QIAGEN N.V.: Ad hoc Announcement according to Art. 17 Market Abuse Regulation QIAGEN to conduct an additional up to $100 million share repurchase program


06-May-2019 / 22:02 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Key word: Share Repurchase Program



Ad hoc Announcement according to Art. 17 Market Abuse Regulation



 



QIAGEN to conduct an additional up to $100 million share repurchase program



 



Venlo, The Netherlands, May 6, 2019 - QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has today passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 19, 2018, and to purchase shares in the Company up to a total of $100 million (or the equivalent Euro amount thereof, in each case excluding transaction costs). Based on the closing price on May 3, 2019, this represents a repurchase volume of approximately 2.5 million shares. The repurchase program is scheduled to begin at the earliest after completion of the current share repurchase program that was announced through an ad hoc announcement on January 31, 2018, and to be completed on December 19, 2019, at the latest, or if the upcoming General Meeting of Shareholders will extend the authorization to repurchase shares, on December 17, 2020, at the latest. Details of the repurchase program will be announced before its actual commencement in line with Article 5 Section (1) and (6) of the EU regulation 596/2014 in conjunction with the regulatory technical standards adopted by the European Commission (so called Safe Harbour Regulation). Repurchased shares will be held in treasury in order to satisfy obligations from employee share-based remuneration plans.



QIAGEN N.V.



Hulsterweg 82



5912 PL Venlo



The Netherlands



ISIN: NL0012169213



Frankfurt Stock Exchange, Regulated Market (Prime Standard)



Contacts QIAGEN N.V.:



Corporate Communications



John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com



Thomas Theuringer, Tel: +49 2013 29 11826 pr@qiagen.com











06-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de





























Language: English
Company: QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

Netherlands
Phone: +31 7735566 - 00
Fax: +31 77 35566-58
E-mail: qiagen@qiagen.com
Internet: www.qiagen.com
ISIN: NL0012169213
WKN: A2DKCH
Indices: MDAX, TecDAX
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, Chicago, NYSE, SIX
EQS News ID: 807787





 
End of Announcement DGAP News Service




807787  06-May-2019 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=807787&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.